Improving awareness, diagnosis and management of invasive fungal infections in Ghana: establishment of the Ghana Medical Mycology Society
- PMID: 36073757
- PMCID: PMC9521337
- DOI: 10.1093/mmy/myac069
Improving awareness, diagnosis and management of invasive fungal infections in Ghana: establishment of the Ghana Medical Mycology Society
Abstract
Invasive fungal infections (IFIs) and medical mycology receive little attention in Ghana. However, the present evolution of biomarker assays for IFIs, offers an opportunity for an increased access to fungal laboratory testing in resource-limited settings, and probably make a case for availability of essential antifungal agents. Using surveys and personal communications, the state of medical mycology and IFI in Ghana were highlighted. Inadequate awareness and insufficient access to fungal diagnostics and therapeutics were identified as the key challenges, the establishment of the Ghana Medical Mycology Society was discussed, and recommendations were made to improve the status quo.
Keywords: Ghana; antifungal agents; diagnostics; invasive fungal infections; research.
Plain language summary
Invasive fungal infections (IFIs) receive little attention in Ghana, despite its growing relevance globally. Using surveys and personal communications, the main challenges were identified, and the formation of the Ghana Medical Mycology Society was discussed as a tool to improve the status quo.
© The Author(s) 2022. Published by Oxford University Press on behalf of The International Society for Human and Animal Mycology.
Similar articles
-
The current state of laboratory mycology in Asia/Pacific: A survey from the European Confederation of Medical Mycology (ECMM) and International Society for Human and Animal Mycology (ISHAM).Int J Antimicrob Agents. 2023 Mar;61(3):106718. doi: 10.1016/j.ijantimicag.2023.106718. Epub 2023 Jan 12. Int J Antimicrob Agents. 2023. PMID: 36640851
-
The role of medical mycology societies in combating invasive fungal infections in low- and middle-income countries: A Nigerian model.Mycoses. 2019 Jan;62(1):16-21. doi: 10.1111/myc.12845. Epub 2018 Oct 8. Mycoses. 2019. PMID: 30184285 Review.
-
The current state of laboratory mycology and access to antifungal treatment in Europe: a European Confederation of Medical Mycology survey.Lancet Microbe. 2023 Jan;4(1):e47-e56. doi: 10.1016/S2666-5247(22)00261-0. Epub 2022 Dec 1. Lancet Microbe. 2023. PMID: 36463916 Review.
-
The Nairobi Declaration 2023: A commitment to address deadly yet neglected fungal diseases in Africa.Med Mycol. 2024 Jan 9;62(1):myad141. doi: 10.1093/mmy/myad141. Med Mycol. 2024. PMID: 38154488
-
Clinicians' challenges in managing patients with invasive fungal diseases in seven Asian countries: An Asia Fungal Working Group (AFWG) Survey.Int J Infect Dis. 2020 Jun;95:471-480. doi: 10.1016/j.ijid.2020.01.007. Epub 2020 Jan 13. Int J Infect Dis. 2020. PMID: 31945491
Cited by
-
Fungal Infections, Treatment and Antifungal Resistance: The Sub-Saharan African Context.Ther Adv Infect Dis. 2024 Nov 13;11:20499361241297525. doi: 10.1177/20499361241297525. eCollection 2024 Jan-Dec. Ther Adv Infect Dis. 2024. PMID: 39544852 Free PMC article. Review.
-
A diverse spectrum of mycoses histologically diagnosed in Ghana: Insights from a 10-year retrospective study.Med Mycol. 2024 Mar 7;62(3):myae015. doi: 10.1093/mmy/myae015. Med Mycol. 2024. PMID: 38383897 Free PMC article.
References
-
- Hoenigl M, Salmanton-García J, Walsh TJet al. . Global guideline for the diagnosis and management of rare mould infections: an initiative of the European Confederation of medical mycology in cooperation with the International Society for Human and Animal Mycology and the American Society of Microbiology. Lancet Infect Dis. 2021; 21: e246–e257. - PubMed
-
- Chen SC, Perfect J, Colombo ALet al. . Global guideline for the diagnosis and management of rare yeast infections: an initiative of the ECMM in cooperation with ISHAM and ASM. Lancet Infect Dis. 2021; 21: e375–e386. - PubMed